Lam Research Total Cost of Revenue increased by 8.8% to $2.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.8%, from $2.41B to $2.93B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.23B | $2.33B | $2.25B | $2.24B | $2.54B | $2.74B | $2.90B | $2.26B | $1.75B | $1.83B | $2.00B | $1.99B | $2.03B | $2.17B | $2.30B | $2.41B | $2.58B | $2.64B | $2.69B | $2.93B |
| QoQ Change | — | +4.4% | -3.4% | -0.2% | +13.0% | +8.0% | +6.0% | -22.0% | -22.7% | +4.5% | +9.5% | -0.4% | +1.9% | +6.6% | +6.4% | +4.5% | +7.3% | +2.2% | +2.1% | +8.8% |
| YoY Change | — | — | — | — | +13.7% | +17.6% | +29.0% | +0.9% | -31.0% | -33.2% | -31.0% | -12.0% | +16.1% | +18.5% | +15.1% | +20.7% | +27.1% | +21.9% | +17.0% | +21.8% |